May 2016
Oncology
Sponsored

Sponsored by an educational grant from Boehringer Ingelheim Vetmedica, Inc. 

Key Points

  • The most recent studies suggest that in the genetically predisposed cat the injection of many substances may contribute to sarcoma development.
  • It is difficult to assess increased risk for sarcoma formation in susceptible cats among different types of injectables.
  • Chronic inflammation at the site of injection is speculated as one contributory factor, but cause and effect have not been established.
  • Heredity may be a factor in determining risk for these sarcomas.

Sign in to continue reading this article

Not registered? Create an account for free to read full articles on www.cliniciansbrief.com.

To access full articles on www.cliniciansbrief.com, please sign in below.

Busy? Sign in Faster. Sign into www.cliniciansbrief.com with your social media account.
Up Next